Effectiveness of 1st dose of BNT162b2 (BioNTech/Pfizer) vaccine for SARS-CoV-2 infection 13 to 24 days after immunization

In this study, short-term effectiveness of the first dose of the BNT162b2 (BioNTech/Pfizer) vaccine againstSARS-CoV-2 infection 13 to 24 days after immunization in a real-world setting was assessed.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news